| scholarly article | Q13442814 |
| P356 | DOI | 10.1191/0961203303LU483OA |
| P698 | PubMed publication ID | 14667100 |
| P2093 | author name string | T Hayashi | |
| K Hasegawa | |||
| P2860 | cites work | Increased spontaneous secretion of IL-6 from B cells of patients with B chronic lymphatic leukaemia (B-CLL) and autoimmunity | Q41671494 |
| CpG-DNA derived from sera in systemic lupus erythematosus enhances ICAM-1 expression on endothelial cells | Q42100130 | ||
| Promotion of lupus in NZB x NZWF1 mice by plasmids encoding interferon (IFN)-gamma but not by those encoding interleukin (IL)-4. | Q44158780 | ||
| CpG oligodeoxynucleotides accelerate reovirus type 2-triggered insulitis in DBA/1 suckling mice | Q44365151 | ||
| IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice | Q47901598 | ||
| Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells | Q47915755 | ||
| Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides | Q56897931 | ||
| A Toll-like receptor recognizes bacterial DNA | Q24290668 | ||
| CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma | Q24568172 | ||
| Anti-dsDNA antibody up-regulates interleukin 6, but not cyclo-oxygenase, gene expression in glomerular mesangial cells: a marker of immune-mediated renal damage? | Q32108129 | ||
| The antigenic properties of bacterial DNA in normal and aberrant immunity | Q34005461 | ||
| Interleukin 6 promotes murine lupus in NZB/NZW F1 mice | Q34228814 | ||
| Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc | Q35126621 | ||
| Pathogenesis of the glomerulonephritis of NZB/W mice | Q36269048 | ||
| Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms | Q36386875 | ||
| CpG DNA: a pathogenic factor in systemic lupus erythematosus? | Q40954780 | ||
| Immune activation by bacterial DNA: a new genetic code | Q41182494 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lupus nephritis | Q1621830 |
| P304 | page(s) | 838-845 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice | |
| P478 | volume | 12 |
| Q44349028 | A safety study of a B-class CpG ODN in Sprague-Dawley rats |
| Q37140639 | An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis". |
| Q36868322 | Antiinfective applications of toll-like receptor 9 agonists |
| Q83116640 | Autoantibodies in systemic lupus erythematosus |
| Q37944412 | Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models |
| Q33941433 | Dendritic cells in systemic lupus erythematosus |
| Q35031736 | Dysfunction of lacrimal and salivary glands in Sjögren's syndrome: nonimmunologic injury in preinflammatory phase and mouse model |
| Q34619324 | Early development of the Toll-like receptor 9 agonist, PF-3512676, for the treatment of patients with advanced cancers |
| Q81277364 | Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB x NZW F mice |
| Q42135044 | Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus |
| Q41670053 | HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus |
| Q36793158 | Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches. |
| Q36526351 | Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides |
| Q36150438 | Immunostimulatory oligonucleotides in therapy of allergic diseases |
| Q47803059 | Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis |
| Q36068780 | Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases? |
| Q36079852 | Interferons as pathogenic effectors in autoimmunity |
| Q37956536 | Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity |
| Q34017633 | Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus |
| Q50571950 | Polarization toward Th1-type response in active, but not in inactive, lupus inhibits late allergic rhinitis in lupus-prone female NZB×NZWF(1) mice. |
| Q37801738 | Role for toll-like receptors in autoimmune disease: The example of systemic lupus erythematosus |
| Q36961012 | Structural requirements and applications of inhibitory oligodeoxyribonucleotides |
| Q56897860 | Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB × NZW mice |
| Q38072067 | Synthetic adjuvants for vaccine formulations: phytol derivatives |
| Q64972967 | Systemic administration of olygodeoxynucleotides with CpG motifs at priming phase reduces local Th2 response and late allergic rhinitis in BALB/c mice. |
| Q36673286 | Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. |
| Q38329839 | TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. |
| Q34106220 | Therapeutic Strategies for SLE Involving Cytokines: Mechanism-Oriented Therapies Especially IFN- Targeting Gene Therapy |
| Q36501229 | Therapeutic potential of Toll-like receptor 9 activation |
| Q36990647 | Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity |
| Q36072422 | Type I interferons (alpha/beta) in immunity and autoimmunity |
| Q51698013 | Ultrastructure of myoepithelial cells as a target cell in sialoadenitis of submandibular glands of lupus-prone female NZBxNZWF1 mice. |
| Q38720050 | Update on the role of plasmacytoid dendritic cells in inflammatory/autoimmune skin diseases |
| Q35790879 | Use of CpG oligodeoxynucleotides as immunoprotective agents |
Search more.